| 1 |
25483839 | Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain. | 2015 Sep |
1 |
| 2 |
22978318 | Half-life prolongation of therapeutic proteins by conjugation to ATIII-binding pentasaccharides: a first-in-human study of CarboCarrier® insulin. | 2013 May |
3 |
| 3 |
23843463 | Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties. | 2013 Sep 6 |
1 |
| 4 |
19888512 | From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile. | 2009 Nov |
1 |
| 5 |
17996279 | Heparin: from animal organ extract to designer drug. | 2008 |
1 |
| 6 |
18433074 | Conjugation of ATIII-binding pentasaccharides to extend the half-life of proteins: long-acting insulin. | 2008 Aug |
1 |
| 7 |
15543318 | Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. | 2004 Nov |
1 |
| 8 |
12765779 | Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparin. | 2003 Jan-Feb |
1 |
| 9 |
14556453 | [From heparin to synthetic antithrombotic oligosaccharides]. | 2003 |
1 |
| 10 |
12004255 | Antithrombin, heparin, and heparan sulfate. | 2002 May |
1 |
| 11 |
10427858 | [New antithrombotic oligosaccharides]. | 1999 May |
1 |
| 12 |
9737884 | Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites. | 1998 Sep 15 |
3 |
| 13 |
9377090 | Combined NMR and molecular modeling study of an iduronic acid-containing trisaccharide related to antithrombotic heparin fragments. | 1997 Jul |
1 |
| 14 |
2432885 | Endothelial binding sites for heparin. Specificity and role in heparin neutralization. | 1986 Sep 15 |
1 |